Clinical trial Recruiting at 1 site Interventional Ages 18 and up

24-hour clear liquid diet before anesthesia for people taking GLP-1 receptor agonists

Official title: Protective Benefits of a Clear Liquid Diet on Residual Gastric Content in Patients Taking Glucagon Like Peptide-1 Receptor Agonist Prior to Anesthesia

Run by The University of Texas Health Science Center, Houston · NCT06654219 · Data updated 2026-11-12

This trial will test whether switching to a clear liquid diet for 24 hours before upper endoscopy reduces leftover stomach contents in people taking GLP-1 receptor agonist medications.

More Pulmonary Aspiration trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment136 (estimated)
SponsorThe University of Texas Health Science Center, Houston
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedOctober 30, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedAugust 4, 2026
Trial IDNCT06654219 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults taking GLP-1 receptor agonists who are scheduled for upper endoscopy and can tolerate ultrasound and positional changes are ideal candidates.

Probably not a fit

Patients with prior gastric surgery or bypass, gastric band, fundoplication, large hiatal hernia, known gastroparesis, pregnancy, recent trauma, or those taking excluded prokinetic or opioid medications were excluded and are unlikely to benefit from these fasting instructions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study enrolls patients taking GLP-1 receptor agonists who are scheduled for upper endoscopy and randomizes them to prolonged fasting from solids with a 24-hour clear liquid diet versus standard NPO instructions. Residual gastric content will be measured by preoperative gastric ultrasound and by direct visualization during endoscopy, with serial ultrasound scans every two hours for subjects with initially at-risk scans. The study also tracks patient symptoms (thirst, hunger, anxiety, nausea, vomiting, bloating, and pain), anesthesia choices, adverse events, and whether duration of GLP-1 RA therapy relates to gastric contents. The trial is conducted at the University of Texas Health Science Center at Houston.

Why it matters

Potential benefit: If successful, this approach could reduce the amount of residual stomach contents and lower aspiration risk for patients on GLP-1 receptor agonists undergoing anesthesia.

How similar studies have gone: Prior evidence indicates GLP-1 receptor agonists can slow gastric emptying, but randomized comparisons of prolonged clear liquid diets before anesthesia in this population are limited, so the approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients taking Glucagon Like Peptide-1 Receptor (GLP-1 RA) agonists
* Undergoing upper endoscopy only - no colonoscopy due to prep

Exclusion Criteria:

* Previous gastric resection or bypass
* Gastric band in situ
* Previous fundoplication
* Large hiatal hernia
* Pregnant patients
* Recent trauma
* Inability to turn to the right lateral decubitus position.
* Patients on erythromycin, metoclopramide, domperidone, opioids.
* Gastroparesis previous

Where it's running

  • The University of Texas Health Science Center at Houston
    Houston, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Sudipta Sen, MD, FASA — The University of Texas Health Science Center, Houston
  • Study coordinator: Sudipta Sen, MD, FASA
  • Email: Sudipta.Sen@uth.tmc.edu
  • Phone: (713) 500-6202

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.